These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17370937)

  • 1. Venice: Europe's new network for vaccination.
    Pastore Celentano L; Lopalco PL; O'Flanagan D; Levy-Bruhl D; Ferro A; Tridente G; Appelgren E; Salmaso S
    Euro Surveill; 2007 Jan; 12(1):E070118.3. PubMed ID: 17370937
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring and assessing vaccine safety: a European perspective.
    Lopalco PL; Johansen K; Ciancio B; De Carvalho Gomes H; Kramarz P; Giesecke J
    Expert Rev Vaccines; 2010 Apr; 9(4):371-80. PubMed ID: 20370548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMS Incorporation in Mass-Vaccination: A Feasibility Study.
    Wooten J; Benedyk K; Patel M; DeFranco M; Pettigrew E; Grover J
    Am J Emerg Med; 2021 Nov; 49():424-425. PubMed ID: 33750663
    [No Abstract]   [Full Text] [Related]  

  • 4. The future of cervical cancer prevention: human papillomavirus vaccines.
    Cadman L
    J Fam Health Care; 2008; 18(4):131-2. PubMed ID: 18754553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the moral dutifulness of using vaccinations].
    Refolo P; González-Melado FJ; Di Pietro ML
    Clin Ter; 2015; 166(1):38-42. PubMed ID: 25756259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public health. Europe's embarrassing problem.
    Kupferschmidt K
    Science; 2012 Apr; 336(6080):406-7. PubMed ID: 22539695
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing and monitoring vaccination coverage levels: lessons from the Americas.
    Dietz V; Venczel L; Izurieta H; Stroh G; Zell ER; Monterroso E; Tambini G
    Rev Panam Salud Publica; 2004 Dec; 16(6):432-42. PubMed ID: 15673487
    [No Abstract]   [Full Text] [Related]  

  • 8. The immunization imperative.
    Martin JF
    Expert Rev Vaccines; 2004 Jun; 3(3):225-7. PubMed ID: 15176937
    [No Abstract]   [Full Text] [Related]  

  • 9. A good shot.
    Meyer CR
    Minn Med; 2002 Feb; 85(2):2. PubMed ID: 11876096
    [No Abstract]   [Full Text] [Related]  

  • 10. [Directions of changes in the Polish Vaccination Programs].
    Grabowski ML
    Przegl Epidemiol; 2003; 57 Suppl 1():15-50. PubMed ID: 12921000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey.
    Dorleans F; Giambi C; Dematte L; Cotter S; Stefanoff P; Mereckiene J; O'Flanagan D; Lopalco PL; D'Ancona F; Levy-Bruhl D;
    Euro Surveill; 2010 Nov; 15(47):. PubMed ID: 21144444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Discussion in the forum of MMW-progress in medicine. Answers to the vaccination problem].
    Schmitt HJ; Schulte G; Stück B; Büsching U
    MMW Fortschr Med; 2001 Jun; 143(25):55-6. PubMed ID: 11469001
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vaccination in Mexico in the context of the "vaccine decades": achievements and challenges].
    Santos JI
    Gac Med Mex; 2014; 150(2):180-8. PubMed ID: 24604001
    [No Abstract]   [Full Text] [Related]  

  • 14. Introduction of human papillomavirus (HPV) vaccination into national immunisation schedules in Europe: Results of the VENICE 2007 survey.
    King LA; Lévy-Bruhl D; O'Flanagan D; Bacci S; Lopalco PL; Kudjawu Y; Salmaso S;
    Euro Surveill; 2008 Aug; 13(33):. PubMed ID: 18761891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination preventable infectious diseases in Germany--current status].
    Bigl S
    Z Arztl Fortbild (Jena); 1995 Jun; 89(3):211-21. PubMed ID: 7668007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can the effects of immunization program decisions on the population be predicted?].
    Leino T; Auranen K
    Duodecim; 2002; 118(1):57-61. PubMed ID: 12228998
    [No Abstract]   [Full Text] [Related]  

  • 18. Are we ready to abrogate compulsory vaccinations for children?
    Martinelli D; Tafuri S; Fortunato F; Cozza V; Germinario CA; Prato R
    Hum Vaccin Immunother; 2015; 11(1):146-9. PubMed ID: 25483528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage.
    Kanitz EE; Wu LA; Giambi C; Strikas RA; Levy-Bruhl D; Stefanoff P; Mereckiene J; Appelgren E; D'Ancona F;
    Vaccine; 2012 Jul; 30(35):5222-8. PubMed ID: 22721901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The childhood vaccination program. Background, status and future].
    Plesner AM; Rønne T
    Ugeskr Laeger; 1994 Dec; 156(50):7497-503. PubMed ID: 7839512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.